Chief Executive Officer
An investor in the public markets since age 10, Brendan had a full-time job in private equity as a biotech investment analyst before he had even finished his undergraduate at Boston College. But he left his position after reading Spencer’s visionary article in STAT News and saw the incredible market opportunity in offering better real-time insight into the landscape of biomedical R&D.
Spencer Hey, Ph.D.
Chief Science Officer
A thought-leader in the fields of ethics, philosophy of science, and meta-research, Spencer was a successful academic at Harvard with more than 70 publications. Having written for years about the gap in tools to support evidence-based judgment, he decided to leave academia in 2020, in order to build Prism with Brendan and bring these tools into existence.